Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

V. Tovazzi · SciRah

Researcher profile · Semantic Scholar

V. Tovazzi

Share profile

V. Tovazzi — researcher profile on SciRah

h-index: 13
Works: 30
Citations: 601

Most-cited papers

Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer
D. Pinato, A. Zambelli, J. Aguilar-Company, M. Bower +60 more
2020Cancer Discovery106 citations Open access
Semantic Scholar
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study
D. Pinato, J. Tabernero, M. Bower, L. Scotti +116 more
2021The Lancet Oncology95 citations Open access
Semantic Scholar
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
D. Pinato, J. Aguilar-Company, D. Ferrante, G. Hanbury +143 more
2022The Lancet Oncology73 citations Open access
Semantic Scholar
Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional case.
E. Roca, M. Pozzari, W. Vermi, V. Tovazzi +5 more
2019Lung Cancer50 citations
Semantic Scholar
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
D. Pinato, L. Scotti, A. Gennari, E. Colomba-Blameble +65 more
2021European Journal of Cancer47 citations Open access
Semantic Scholar
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
G. Dettorre, S. Dolly, A. Loizidou, J. Chester +57 more
2021Journal for ImmunoTherapy of Cancer39 citations Open access
Semantic Scholar
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients
D. Pinato, A. Zambelli, J. Aguilar-Company, M. Bower +47 more
202033 citations
Semantic Scholar
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
A. Cortellini, J. Tabernero, U. Mukherjee, R. Salazar +123 more
2023The Lancet Oncology29 citations Open access
Semantic Scholar
Eight‐week interval in flushing and locking port‐a‐cath in cancer patients: A single‐institution experience and systematic review
Carla Fornaro, Maria Piubeni, V. Tovazzi, D. Cosentini +12 more
2018European Journal of Cancer Care24 citations Open access
Semantic Scholar
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis.
C. Gurizzan, M. Zamparini, M. Volante, V. Tovazzi +6 more
2021Endocrine-Related Cancer22 citations
Semantic Scholar
Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial.
P. Bossi, A. Alberti, C. Bergamini, C. Resteghini +15 more
2025European Journal of Cancer18 citations
Semantic Scholar
Immunotherapy followed by cetuximab in locally advanced/metastatic (LA/M) cutaneous squamous cell carcinomas (cSCC): The I-TACKLE trial.
P. Bossi, A. Alberti, C. Bergamini, C. Resteghini +15 more
2022Journal of Clinical Oncology14 citations
Semantic Scholar
Excess of second tumors in denosumab-treated patients: a metabolic hypothesis.
V. Tovazzi, Alberto Dalla Volta, R. Pedersini, V. Amoroso +1 more
2019Future Oncology13 citations Open access
Semantic Scholar
Should everolimus be stopped after radiological progression in metastatic insulinoma? A “cons” point of view
V. Tovazzi, V. Ferrari, Alberto Dalla Volta, F. Consoli +2 more
2020Endocrine8 citations
Semantic Scholar
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures
Alberto Dalla Volta, F. Valcamonico, R. Pedersini, Carla Fornaro +10 more
2020Frontiers in Oncology7 citations Open access
Semantic Scholar
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma
S. Grisanti, D. Cosentini, V. Tovazzi, S. Bianchi +5 more
2018Supportive Care in Cancer7 citations
Semantic Scholar
319O The systemic pro-inflammatory response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection
G. Dettorre, N. Diamantis, A. Loizidou, M. Piccart +16 more
2020Annals of Oncology5 citations Open access
Semantic Scholar
A Rare Complex BRAF Mutation Involving Codon V600 and K601 in Primary Cutaneous Melanoma: Case Report
F. Consoli, G. Barbieri, Matteo Picciolini, D. Medicina +8 more
2020Frontiers in Oncology4 citations Open access
Semantic Scholar
Progression of vertebral fractures in metastatic melanoma and non-small cell lung cancer patients given immune checkpoint inhibitors
M. Prina, A. Alberti, V. Tovazzi, M. Ravanelli +10 more
2024Journal of Bone Oncology3 citations Open access
Semantic Scholar
A phase II, open-label study to improve compliance and time of treatment after obtaining complete response (CR) through a tailored schedule of sonidegib in locally advanced basal cell carcinomas (LA BCC) – the SONIBEC trial
C. Resteghini, M. Variolo, Sara Farinatti, Andrea Alberti +15 more
2026EJC Skin Cancer2 citations Open access
Semantic Scholar
A phase II, open-label study to improve compliance and time of treatment after obtaining complete response (CR) through a tailored schedule of sonidegib in locally advanced basal cell carcinomas (laBCC): The SONIBEC trial.
C. Resteghini, Sara Farinatti, Andrea Alberti, V. Tovazzi +13 more
2025Journal of Clinical Oncology1 citations
Semantic Scholar
Maintenance everolimus beyond progression in pancreatic NET to control insulinoma syndrome
V. Tovazzi, V. Ferrari, A. Berruti
2021Endocrine1 citations Open access
Semantic Scholar
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic
C. Gurizzan, R. Pedersini, Carla Fornaro, C. Sardini +16 more
2021Frontiers in Oncology1 citations Open access
Semantic Scholar
Impact of baseline nutritional and inflammatory markers on safety and efficacy of immune checkpoint inhibitors in cancer patients: a retrospective, monocentric study
A. Baggi, D. Smussi, L. Lorini, Erika Stucchi +12 more
2026Discover Oncology0 citations Open access
Semantic Scholar
1664P Long-term updates of the I-TACKLE trial: pembrolizumab (P) followed by cetuximab (C) in locally advanced/metastatic (LA/M) cutaneous squamous cell carcinomas (cSCC)
C. Resteghini, C. Bergamini, A. Alberti, S. Farinatti +16 more
2025Annals of Oncology0 citations Open access
Semantic Scholar
Clinical and pathological prognostic factors in Merkel cell carcinoma.
V. Tovazzi, L. Lorini, S. Battocchio, M. Zannoni +15 more
2022Journal of Clinical Oncology0 citations
Semantic Scholar
Abstract 701: The acute phase response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection as quantified by the OnCovid Inflammatory Score
G. Dettorre, S. Dolly, A. Loizidou, J. Chester +46 more
2021COVID-19 and Cancer0 citations
Semantic Scholar
Abstract S01-03: The acute phase response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection as quantified by the OnCovid Inflammatory Score
G. Dettorre, S. Dolly, A. Loizidou, J. Chester +46 more
2021Oral Presentations - Proffered Abstracts0 citations
Semantic Scholar
Merkel Cell Carcinoma
F. Consoli, V. Tovazzi, S. Battocchio, W. Vermi +2 more
2021Neuroendocrine Neoplasia Management0 citations
Semantic Scholar
1693P Accurate triage may be efficacious in selecting patients who could safely continue anticancer therapy during SARS-CoV-2 pandemic
C. Gurizzan, R. Pedersini, Carla Fornaro, C. Sardini +16 more
2020Annals of Oncology0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Grisanti×15
Invite
S. Grisanti — researcher profile on SciRah
A. Berruti×13
Invite
A. Berruti — researcher profile on SciRah
E. Seguí×11
Invite
E. Seguí — researcher profile on SciRah
D. Pinato×10
Invite
D. Pinato — researcher profile on SciRah

×10

Invite

C. Cruz — researcher profile on SciRah

J. Aguilar-Company×9

Invite

J. Aguilar-Company — researcher profile on SciRah

Invite

C. Sng — researcher profile on SciRah

Invite

R. Mesía — researcher profile on SciRah

Invite

F. Biello — researcher profile on SciRah

Invite

G. Rizzo — researcher profile on SciRah

M. Libertini×9

Invite

M. Libertini — researcher profile on SciRah

Invite

R. Bertulli — researcher profile on SciRah